Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

People who were hospitalised with COVID-19 and continued to experience symptoms five months later, show limited further recovery one year after hospital discharge according to the latest results of a major national study.

Illustrative image of the Coronavirus © Shutterstock

The latest findings of the PHOSP-COVID study, which involves several researchers from the University of Oxford including Professor Ling-Pei Ho of the MRC Human Immunology Unit (MRC HIU), have been published on the medRxiv pre-print website.

Researchers from 53 institutions and 83 hospitals across the UK assessed 2,230 adults who had been hospitalised with COVID-19. The researchers found that one year after hospital discharge, fewer than 3 in 10 patients on the study reported they felt fully recovered, largely unchanged from 2.5 in 10 at five months. The most common ongoing symptoms were fatigue, muscle pain, physically slowing down, poor sleep and breathlessness.

Participants felt their health-related quality of life remained substantially worse one year after hospital discharge, compared to pre-COVID. This suggests the physical and mental health impairments reported in the study are unlikely to be pre-existing conditions.

Read the full story on the MRC Weatherall Institute of Molecular Medicine website. 

 

 

Similar stories

Oxford biologists and engineers awarded £2 million to grow human neurons as brain circuits in chambers made of oil

The circuits of the brain linking together the regions known as the midbrain, the striatum and the cortex are critical to understanding disorders such as Parkinson’s disease, addiction and autism. Understanding and modelling how the circuit works in human neurons has been difficult, mainly due to the inaccessibility of the human brain and the limitations of current technologies to reliably grow circuits of human neurons in the laboratory.